
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 341 - COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
##### Subpart C - Labeling
###### ยง 341.85 Labeling of permitted combinations of active ingredients.
####### For permitted combinations containing an antihistamine combined with an oral antitussive.

(4)The labeling states the warning "When using this product [in bold type] [bullet] may cause marked drowsiness." The word "marked" may be deleted from the warning upon petition under the provisions of ยง 10.30 of this chapter provided adequate data are submitted to demonstrate that the combination product does not cause a significant increase in drowsiness as compared with each active ingredient when tested alone. The petition and the data it contains will be maintained in a permanent file for public review in the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
